Precision Medicine Trial Using a Personalised Approach Reports Preliminary Findings on Cognitive Function in Patients with Mild Cognitive Impairment and Early Dementia

Contributed by: PR Newswire

Tags

Evanthea-Study-Result

More Like This

UK Pilot launched to detect early signs of dementia & improve brain health

Advances in science set to transform treatments for people living with dementia

Dementia Mission Competition Selects Four Companies For Innovative Alzheimer’s Biomarker Study

Lilly and Leading Alzheimer's Disease Experts Call for Urgent Action to Close Diagnostic Gaps at Alzheimer Europe Conference

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

PR Newswire associated0

RESEARCH ADVANCES FROM THE 2025 ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE

PR Newswire associated0

Cumulus Neuroscience Presents Data at AAIC 2024 Annual Meeting and Technology and Dementia Preconference

PR Newswire associated0

Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual Meeting